Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse
  1. Ablage / 
  2. Detailsuche  / 
  3. Datensatz ansehen

Datensatz

DATENSATZ AKTIONENEXPORT
 
 
DownloadE-Mail
 Lokale TagsFreigabegeschichteDetailsÜbersicht
  The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity

Klotz, L., Burgdorf, S., Dani, I., Saijo, K., Flossdorf, J., Hucke, S., et al. (2009). The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. The Journal of experimental medicine, 206(10), 2079-89. doi:10.1084/jem.20082771.

Item is

 

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:
Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-0028-6445-3 Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-0028-6446-1
Genre: Zeitschriftenartikel

Dateien

einblenden: Dateien
ausblenden: Dateien
:
Klotz-2009-The nuclear receptor.pdf (beliebiger Volltext), 5MB
 
Datei-Permalink:
-
Name:
Klotz-2009-The nuclear receptor.pdf
Beschreibung:
-
OA-Status:
Sichtbarkeit:
Privat
MIME-Typ / Prüfsumme:
application/pdf
Technische Metadaten:
Copyright Datum:
-
Copyright Info:
-
Lizenz:
-

Externe Referenzen

einblenden:
ausblenden:
externe Referenz:
http://www.ncbi.nlm.nih.gov/pubmed/19737866 (beliebiger Volltext)
Beschreibung:
-
OA-Status:
externe Referenz:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757877/pdf/JEM_20082771.pdf (beliebiger Volltext)
Beschreibung:
-
OA-Status:

Urheber

einblenden:
ausblenden:
 Urheber:
Klotz, L., Autor
Burgdorf, S., Autor
Dani, I., Autor
Saijo, K., Autor
Flossdorf, J., Autor
Hucke, S., Autor
Alferink, J., Autor
Nowak, N., Autor
Beyer, M., Autor
Mayer, G., Autor
Langhans, B., Autor
Klockgether, T., Autor
Waisman, A., Autor
Eberl, G., Autor
Schultze, J., Autor
Famulok, M.1, Autor
Kolanus, W., Autor
Glass, C., Autor
Kurts, C., Autor
Knolle, P. A., Autor
Affiliations:
1External Organizations, ou_persistent22              

Inhalt

einblenden:
ausblenden:
Schlagwörter: Animals Cell Differentiation DNA-Binding Proteins/metabolism Encephalomyelitis, Autoimmune, Experimental/*prevention & control Humans Interleukin-17/physiology Mice Mice, Inbred C57BL Multiple Sclerosis/*prevention & control Nuclear Receptor Co-Repressor 2 Nuclear Receptor Subfamily 1, Group F, Member 3 PPAR gamma/*physiology Promoter Regions, Genetic Receptors, Retinoic Acid/genetics Receptors, Thyroid Hormone/genetics Repressor Proteins/metabolism T-Lymphocytes, Helper-Inducer/*cytology
 Zusammenfassung: T helper cells secreting interleukin (IL)-17 (Th17 cells) play a crucial role in autoimmune diseases like multiple sclerosis (MS). Th17 differentiation, which is induced by a combination of transforming growth factor (TGF)-beta/IL-6 or IL-21, requires expression of the transcription factor retinoic acid receptor-related orphan receptor gamma t (ROR gamma t). We identify the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR gamma) as a key negative regulator of human and mouse Th17 differentiation. PPAR gamma activation in CD4(+) T cells selectively suppressed Th17 differentiation, but not differentiation into Th1, Th2, or regulatory T cells. Control of Th17 differentiation by PPAR gamma involved inhibition of TGF-beta/IL-6-induced expression of ROR gamma t in T cells. Pharmacologic activation of PPAR gamma prevented removal of the silencing mediator for retinoid and thyroid hormone receptors corepressor from the ROR gamma t promoter in T cells, thus interfering with ROR gamma t transcription. Both T cell-specific PPAR gamma knockout and endogenous ligand activation revealed the physiological role of PPAR gamma for continuous T cell-intrinsic control of Th17 differentiation and development of autoimmunity. Importantly, human CD4(+) T cells from healthy controls and MS patients were strongly susceptible to PPAR gamma-mediated suppression of Th17 differentiation. In summary, we report a PPAR gamma-mediated T cell-intrinsic molecular mechanism that selectively controls Th17 differentiation in mice and in humans and that is amenable to pharmacologic modulation. We therefore propose that PPAR gamma represents a promising molecular target for specific immunointervention in Th17-mediated autoimmune diseases such as MS.

Details

einblenden:
ausblenden:
Sprache(n):
 Datum: 2009
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: -
 Identifikatoren: Anderer: 19737866
DOI: 10.1084/jem.20082771
ISSN: 1540-9538 (Electronic)
ISSN: 0022-1007 (Linking)
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: The Journal of experimental medicine
  Alternativer Titel : J. Exp. Med.
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: -
Seiten: - Band / Heft: 206 (10) Artikelnummer: - Start- / Endseite: 2079 - 89 Identifikator: -